Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. April 2022 13:00 ET | Quelle: Anaveon

Anaveon presents compelling data from the Phase I/II study of ANV419 during the AACR Annual Meeting 2022

- ANV419 is very well-tolerated and demonstrates exceptional safety with strong pharmacodynamic effects and excellent IL-2Rβγ selectivity - - A Phase II program of ANV419 has been initiated in...
16. Dezember 2021 02:00 ET | Quelle: Anaveon

Anaveon to raise CHF 110 million in oversubscribed Series B financing

- Leading international syndicate led by Forbion and corner-stoned by founding investor Syncona- Confirms depth of support for Anaveon’s approach to developing engineered cytokines in multiple...
14. September 2020 08:00 ET | Quelle: Jeito Capital

Jeito Capital co-leads $110 Million Series A Financing in Neogene Therapeutics

Jeito Capital co-leads $110 Million Series A Financing in Neogene Therapeutics Neogene becomes Jeito Capital’s first investment following the fund I launch in January 2020Round co-led by Jeito...